SYK · Q2 2026

Archived report (Q2 2026). Latest deep dive →

US GAAP, Q2 2026 · released Jul 30

The quarter in brief

A strong recovery quarter—9.4% sales growth and a 158M tariff-charge reversal drove operating margin up 670bps and net earnings up 44%, though adjusted EPS growth of 18% better reflects underlying momentum post cyber-incident.

Net Earnings

$1,276M

up 44.3% y/y

Revenue

$6,589M

up 9.4% y/y

Operating Income

$1,659M

up 49.1% y/y

Gross Profit

$4,498M

up 17.1% y/y

All figures in $M.

Sankey diagram of SYK earnings report for Q2 2026: revenue, costs and profit
Line item	Amount and change
MedSurg & Neurotechnology	$3,625 · +9.7%
Orthopaedics	$2,964 · +9.1%
Revenue	$6,589 · +9.4%
Cost of Sales	$2,091 · -4.1%
Gross Profit	$4,498 · +17.1% · 68.3% margin
SG&A	$2,229 · +7.2%
R&D & Engineering	$434 · +6.6%
Amortization & Impairments	$176 · -19.6%
Operating Income	$1,659 · +49.1% · 25.2% margin
Other Income (Expense), net	-$95 · -2.1%
Pretax Income	$1,564 · +53.9%
Income Taxes	$288 · +118.2%
Net Earnings	$1,276 · +44.3% · $3.30 diluted EPS

Verdict: a strong recovery quarter—9.4% sales growth and a 158M tariff-charge reversal drove operating margin up 670bps and net earnings up 44%, though adjusted EPS growth of 18% better reflects underlying momentum post cyber-incident.

6-mo OCF $1,842M (+35% y/y); dividends paid $674M (6mo); narrowed FY26 guidance to 8.3-9.3% organic growth and adjusted EPS of $14.95-$15.10.

Source and notation

* marks non-cash / ≈ estimated. Source: Stryker press release / 10-Q (SEC EDGAR).

Open as an image: SYK, Q2 2026 (PNG) ↗ · for sharing and presentations · free to reuse, CC BY 4.0

Cite / embed this chart

Free to use in articles, research and social posts with credit to Who Reports Today and a link — licensed under CC BY 4.0 (terms).

Credit line

Chart: “SYK Q2 2026: where the revenue went” by Who Reports Today, https://whoreportstoday.com/t/syk/q2-2026. Licensed under CC BY 4.0.

HTML: image with link and credit

<figure>
  <a href="https://whoreportstoday.com/t/syk/q2-2026"><img src="https://whoreportstoday.com/t/syk/q2-2026/sankey.png" alt="SYK Q2 2026: where the revenue went" loading="lazy" style="max-width:100%;height:auto"></a>
  <figcaption>Source: <a href="https://whoreportstoday.com/t/syk/q2-2026">Who Reports Today</a>, licensed under <a href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0</a></figcaption>
</figure>

Direct link to the image (PNG)

https://whoreportstoday.com/t/syk/q2-2026/sankey.png

Link for your article text

<a href="https://whoreportstoday.com/t/syk/q2-2026">SYK Q2 2026 earnings chart (Who Reports Today)</a>

This is an archived report: the image at this link won’t change. If you change the chart (crop, translate), say so in the credit. Company logos and trademarks are not covered by the license.

SYK — Stryker is a medical technology company that develops and manufactures surgical equipment, orthopedic implants, and neurotechnology products.

The company is headquartered in Kalamazoo, Michigan.

More reports: TECH · Q4 FY2026 · TMO · Q3 2026 · UHS · Q3 2026 · UNH · Q3 2026 · VEEV · Q2 FY2027 · VRTX · Q2 2026 · VTRS · Q2 2026 · WAT · Q2 2026 · WST · Q3 2026 · ZBH · Q2 2026 · all reports

SYK · Q2 2026

Company reports